Insider Trading Summary for Adventrx Pharmaceuticals Inc. (SVRA): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
18-Nov-24 12:33 PM View:	18-Nov-24 Purchase $287.60K	Ramsay David A Director		Adventrx Pharmaceuticals Inc. - SVRA	6% 2.2M to 2.32M	0	0	--	--	Show Txns Hide Txns

29-Dec-23 4:33 PM View:	28-Dec-23 Sale ($188.92K)	Elam Nevan C Director		Adventrx Pharmaceuticals Inc. - SVRA	(23%) 29.24K to 22.5K	0	0	--	--	Show Txns Hide Txns

15-Dec-23 5:33 PM View:	14-Dec-23 Grant 0	Hawkins Richard J Director		Adventrx Pharmaceuticals Inc. - SVRA	1755% 1.9K to 35.24K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 7:55 AM View:	19-Nov-24 Purchase $59.07K	McCracken Joseph S Director		Adventrx Pharmaceuticals Inc. - SVRA	25% 168.34K to 210.84K	0	0	--	--	Show Txns Hide Txns

29-Dec-23 4:34 PM View:	28-Dec-23 Private Sale ($47.13K)	Lowrance David L Chief Financial Officer		Adventrx Pharmaceuticals Inc. - SVRA	41% 242.79K to 342.36K	0	0	--	--	Show Txns Hide Txns

15-Dec-23 5:35 PM View:	14-Dec-23 Grant 0	van Es-Johansson An Director		Adventrx Pharmaceuticals Inc. - SVRA	100% 0 to 22.5K	0	0	--	--	Show Txns Hide Txns

15-Dec-23 6:10 PM View:	14-Dec-23 Grant 0	Sun Ricky Director		Adventrx Pharmaceuticals Inc. - SVRA	100% 0 to 22.5K	0	0	--	--	Show Txns Hide Txns

29-Dec-23 4:35 PM View:	28-Dec-23 Sale ($395.90K)	Pauls Matthew CHIEF EXECUTIVE OFFICER Director		Adventrx Pharmaceuticals Inc. - SVRA	23% 1.05M to 1.28M	0	0	--	--	Show Txns Hide Txns

18-Dec-23 4:05 PM View:	14-Dec-23 Grant 0	Pratt Raymond Dennis Chief Medical Officer		Adventrx Pharmaceuticals Inc. - SVRA	94% 160.0K to 310.0K	0	0	--	--	Show Txns Hide Txns

15-Dec-23 5:51 PM View:	14-Dec-23 Grant 0	Lutz Robert Matthew Chief Operating Officer		Adventrx Pharmaceuticals Inc. - SVRA	114% 140.0K to 300.0K	0	0	--	--	Show Txns Hide Txns

22-Jul-24 4:16 PM View:	21-Jul-24 Payment of Exercise ($1.70K)	Erickson Anne Chief Business Officer		Adventrx Pharmaceuticals Inc. - SVRA	0% 354.08K to 353.32K	0	0	--	--	Show Txns Hide Txns

27-Sep-24 4:35 PM View:	25-Sep-24 Grant 0	Parker Braden C. Chief Commercial Officer		Adventrx Pharmaceuticals Inc. - SVRA	100% 0 to 85.0K	0	0	--	--	Show Txns Hide Txns

Adventrx Pharmaceuticals Inc. (SVRA)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--